Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-113704
Filing Date
2025-11-21
Accepted
2025-11-21 17:18:10
Documents
2
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0266630-6k_psyence.htm 6-K 9170
2 PRESS RELEASE, DATED NOVEMBER 12, 2025 ea026663001ex99-1_psyence.htm EX-99.1 20876
  Complete submission text file 0001213900-25-113704.txt   31202
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO Ontario, Canada
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO Ontario, Canada 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41937 | Film No.: 251509020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)